Anti-cold medication :: Consumers survey results of for 1 quarter of 2018

Consumers survey results of for 1 quarter of 2018 in category

Cold and Flu / Anti-cold medication

The annual ratings by results of Consumers survey calculated as average arithmetic mean rank, obtained in each of 4 quarters of year.

	I quarter (january—march)
	II quarter (april—june)
	III quarter (july—september)
	IV quarter (october—december)

1.	2	Amizon (Farmak)	25.00%	5

2.	4	Афлубін (Perrigo)	22.92%	4.58

3.	4	Фервекс (Bristol-Myers Squibb)	18.75%	3.75

4.	1	Фармацитрон (Pharmascience)	16.67%	3.33

5.	6	Arbidol (OTC-Фарм)	14.58%	2.92

5.	3	Колдрекс (GlaxoSmithKline)	14.58%	2.92

7.	5	Анаферон (Materia Medica – Ukraine)	12.50%	2.50

8.	6	Ergoferon (Materia Medica – Ukraine)	10.42%	2.08

9.	3	Хелпекс (Movi Health GmbH)	8.33%	1.67

9.	6	Вікс Актив (Dr. Reddy’s)	8.33%	1.67

9.	~	Грип-Хеель (Heel)	8.33%	1.67

9.	4	Комбігрип (ORGANOSYN)	8.33%	1.67

13.	5	IRS 19 (Abbott Laboratories)	6.25%	1.25

13.	6	Гриппостад (Nizhpharm)	6.25%	1.25

13.	3	Колдфлю Екстра (Genom Biotech)	6.25%	1.25

13.	4	Мілістан (Mili Healthcare)	6.25%	1.25

13.	~	Маліпін (Vishpha \| Фармацевтична фабрика Vishpha)	6.25%	1.25

13.	5	Терафлю (Novartis OTC)	6.25%	1.25

19.	4	Gripex (Delta Medical)	4.17%	0.83

19.	~	Антигрипін (Національна гомеопатична спілка)	4.17%	0.83

19.		Грипфлю (Ananta Medicare Ltd.)	4.17%	0.83

19.	~	Розтиран (Vishpha \| Фармацевтична фабрика Vishpha)	4.17%	0.83

–.	~	~~Інсті (Herbion)~~	~~4.17%~~	~~0.83~~

23.	6	Antiflu (Bayer)	2.08%	0.42

23.	~	Грипмакс (Unipharm, Inc)	2.08%	0.42

23.	6	Грипомед (Red star)	2.08%	0.42

23.	~	Колдрін (Teva)	2.08%	0.42

23.	5	Ринза (Johnson & Johnson)	2.08%	0.42

–.	5	Rinicold (Shreya Life Sciences)	0.00%	0

–.		Лекадол плюс C (Sandoz)	0.00%	0

–.	2	Флюколд-N (Nabros Pharma)	0.00%	0

Using this rating is only possible with obligatory link to the source.

This rating was built as a result of the study of social preferences in 2018, under the “Favorites of Success” Contest in Ukraine and it’s the free information. In case of full or partial republishing of the information drawn from this rating, it is obligatory to mention the name of the “Favorites of Success” Contest in printed publications, or put an active hyperlink to this page in the electronic media.

Advanced reporting booklet about the study, including demographics of the respondents, by regional breakdown, information roll-call of ad hoc judges etc, can also be obtained from managers of the contest.